ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Advisory Panel Unanimously Favors New Stool DNA Colorectal Screening Test

March 28, 2014

U.S. Preventive Services Task Force Recommends Mammograms For Over-40.

February 22, 2002

Radiation Oncologist Objects To ACR Comments Results

November 27, 1981

NCAB Ok’s Funding First Three Years Of Diet Trial

December 7, 1990

Capitol Hill: Trial Results Represent Culmination of Research, Klausner Tells House

March 19, 1999

In Brief: Judge Rules FDA Modernization Act Violates First Amendment Over Publications Policy

August 6, 1999